Article

ARVO 2023: Risk factors for glaucoma associated with BMI, waist circumference, and metabolic syndrome

Author(s):

Body mass index (BMI), central obesity, and the metabolic syndrome may be deciding risk factors in glaucoma.

an image of a woman standing on a scale with a measuring tape in front of her. (Image Credit: AdobeStock/NewAfrica)

The likelihood of development of glaucoma was less in patients who were overweight, obese, or had central obesity. (Image Credit: AdobeStock/NewAfrica)

Jennifer E. Lee, MD, from the University of California Los Angeles David Geffen School of Medicine, Los Angeles, and colleagues found that the likelihood of development of glaucoma was less in patients who were overweight, obese, or had central obesity. However, those with metabolic syndrome or a high metabolic syndrome severity score were more likely to develop glaucoma, findings that suggested that obesity alone is not enough to increase their glaucoma risk.

The investigators reported these findings at the Association for Research in Vision and Ophthalmology annual meeting.

The goal of this study was to improve the outcomes of patients with glaucoma, considering the worldwide impact that the disease has on vision. Obesity has been considered as a potential risk factor for the disease, but the results of various studies to now have not been definitive in that regard.

The investigators used the National Institute of Health’s “All of Us” (AoU) database to evaluate the association between glaucoma and various parameters, ie, body mass index (BMI), central obesity, and the metabolic syndrome.

The researchers searched the AoU database for patients 40 years and older who had electronic health record and BMI data available. They explained that the primary exposures were the BMI, central obesity, metabolic syndrome and the metabolic syndrome severity score, the last of whichis based on confirmatory factor analysis of components of the metabolic syndrome, ie, blood pressure, triglycerides, high density lipoprotein, central obesity, and blood glucose. The electronic health records were used to identify the diagnosis of glaucoma.

Of the 156,476 patients included in the analysis, 5.52% had glaucoma.

Based on multivariate logistic regression analyses that adjusted for age, sex, race, education, and income in all analyses and for arterial pressure, hyperlipidemia, and diabetes in the analyses of BMI and central obesity, the patients who were overweight, obese, or had central obesity had a lower risk of developing glaucoma.

In contrast, the patients with the metabolic syndrome and a high metabolic syndrome severity score had higher odds of having glaucoma compared to those without.

The authors concluded that their results suggested that the metabolic syndrome, rather than obesity alone, may be a risk factor for glaucoma and they called for future research to examine the role of the metabolic syndrome in the pathogenesis of glaucoma. Such research would be beneficial to identify potential strategies for improved disease management, they emphasized.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.